Schedule 13D ownership disclosure

AIM IMMUNOTECH INC

Common Stock, par value $0.001 per share · CUSIP: 00901B105

Event date: 2024-12-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Todd DeutschReported CIK 0001709836

    Shares: 1,716,100 · Class: 2.7%

  • Ted D. KellnerReported CIK 0001187524

    Shares: 1,493,000 · Class: 2.3%

  • Paul W. Sweeney

    Shares: 2,000 · Class: 0%

  • Wayne SpringateReported CIK 0001465652

    Shares: 4,660 · Class: 0.01%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-24-139356
Form type
SCHEDULE 13D/A
Filer
AIM ImmunoTech Inc.
CIK
CIK 946644
Filed
Dec 23, 2024
Reporting period
Dec 19, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub